Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

EMA CHMP recommends approval of Sandoz adalimumab biosimilar

June 4, 2018

FDA approves Olumiant 2 mg for moderate to severe rheumatoid arthritis

June 4, 2018

Astellas submits application for marketing approval of peficitinib in Japan

June 1, 2018

Phase II EQUATOR study of filgotinib in psoriatic arthritis meets primary endpoint

May 31, 2018

ImmuPharma releases further data analysis from pivotal trial of Lupuzor in SLE

May 29, 2018

Croma-Pharma identifies H2S-releasing compounds

May 28, 2018

Lupin submits MAA to the EMA for etanercept biosimilar

May 28, 2018

First patient enrolled in SARA-INT study of Sarconeos in sarcopenia

May 28, 2018

Chugai seeks Japanese approval for Actemra for adult-onset Still's disease

May 25, 2018

European Commission approves Sandoz's infliximab biosimilar Zessly

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...